China Biologic Produ (CBPO) Fundamental Analysis & Valuation
NASDAQ:CBPO
Current stock price
119.99
+1.98 (+1.68%)
At close:
120.04
+0.05 (+0.04%)
After Hours:
This CBPO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
No Fundamental Analysis report for CBPO not available.
CBPO Fundamentals: All Metrics, Ratios and Statistics
119.99
+1.98 (+1.68%)
Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.62%
Inst Owner Change0%
Ins Owners39.98%
Ins Owner Change0%
Market Cap4.72B
Revenue(TTM)524.37M
Net Income(TTM)152.29M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP8.12%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.07 | ||
| Fwd PE | 27.9 | ||
| P/S | 9.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 2.39 | ||
| P/tB | N/A | ||
| EV/EBITDA | 18.67 |
EPS(TTM)3.99
EY3.33%
EPS(NY)4.3
Fwd EY3.58%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS13.32
BVpS50.2
TBVpSN/A
PEG (NY)3.87
PEG (5Y)7.41
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.12% | ||
| ROE | 7.71% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 37.26% | ||
| PM (TTM) | 29.04% | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.25
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 12.01 | ||
| Quick Ratio | 12.01 | ||
| Altman-Z | 19.23 |
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.78%
EPS 3YN/A
EPS 5Y4.06%
EPS Q2Q%-25.71%
EPS Next Y7.77%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.09%
Revenue growth 3YN/A
Revenue growth 5Y12.08%
Sales Q2Q%1.78%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A
China Biologic Produ / CBPO Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for China Biologic Produ?
ChartMill assigns a fundamental rating of 5 / 10 to CBPO.
Can you provide the valuation status for China Biologic Produ?
ChartMill assigns a valuation rating of 2 / 10 to China Biologic Produ (CBPO). This can be considered as Overvalued.
How profitable is China Biologic Produ (CBPO) stock?
China Biologic Produ (CBPO) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for CBPO stock?
The Price/Earnings (PE) ratio for China Biologic Produ (CBPO) is 30.07 and the Price/Book (PB) ratio is 2.39.
What is the financial health of China Biologic Produ (CBPO) stock?
The financial health rating of China Biologic Produ (CBPO) is 8 / 10.